As of Nov 21, 2024, the CRGX stock has a P/E ratio of 0.2. The calculation is based on the latest EPS of $78.85 and the stock price of $15.73 per share.
Year | PE ratio | Change |
---|---|---|
2023 | N/A | N/A |
2022 | N/A | N/A |
2021 | N/A | N/A |
When compared to its peer stocks AMGN and GILD, CRGX's PE ratio is lower. CARGO Therapeutics is currently trading at a lower PE ratio (0.2) than its peers average of 34.75.
Stock name | PE ratio | Market cap |
---|---|---|
CRGX CARGO Therapeutics Inc | 0.2 | $724.02M |
BIIB Biogen Inc | 14.22 | $23.03B |
REGN Regeneron Pharmaceuticals Inc | 17.22 | $81.81B |
AMGN Amgen Inc | 36.74 | $155.83B |
SRPT Sarepta Therapeutics Inc | 70.83 | $10.55B |
GILD Gilead Sciences Inc | 897.6 | $111.86B |
VRTX Vertex Pharmaceuticals Inc | N/A | $115.98B |
ALNY Alnylam Pharmaceuticals Inc | N/A | $31.83B |
MRNA Moderna Inc | N/A | $14.72B |
NVAX Novavax Inc | N/A | $1.29B |
As of Nov 21, 2024, CRGX stock has a price to earnings ratio of 0.2.
CRGX's PE ratio is low because its earnings per share (EPS) is high relative to its stock price.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Nov 21, 2024), CARGO Therapeutics's share price is $15.73. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $78.85. Therefore, CARGO Therapeutics's price to earnings ratio for today is 0.2. PE RATIO(0.2) = STOCK PRICE($15.73) / TTM EPS($78.85)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.